People
Dynavax announces stock options at exercise price of USD17.14 per share under Nasdaq Listing Rule 5635(c)(4)
19 October 2021 - Biopharmaceutical company Dynavax Technologies Corporation (Nasdaq:DVAX) announced on Monday that it awarded non statutory stock options to one newly-hired employee as material induc...
Geneoscopy names new CMO
19 October 2021 - Geneoscopy Inc., a US-based life sciences company, announced on Monday that it has named Haytham Gareer, MD, PhD as its new chief medical officer.Dr Gareer is a trained surgical onco...
Providence names new CMO
18 October 2021 - Providence, a health system in the United States, announced on Friday that it has named Hoda Asmar, MD, MBA as its new chief medical officer.In the new role, Dr Asmar will be a key m...
SpinaFX Medical names new COO
18 October 2021 - SpinaFX Medical Inc., a Canada-based minimally invasive image-guided therapy start-up, announced on Friday that it has named John Soloninka as its new chief operating officer.Solonin...
Navidea Biopharmaceuticals Names Farb-Horch and Winkler to Board of Directors
15 October 2021 - - US-based precision immunodiagnostic agents and immunotherapeutics company Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) has appointed Thomas Forest Farb-Horch and Agnieszk...
Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense Tavneos, an Adjunctive Treatment for ANCA-Associated Vasculitis
15 October 2021 - - US-based Amber Specialty Pharmacy will begin dispensing Tavneos (avacopan), a first of its kind orally-administered selective complement 5a receptor inhibitor, as an adjunctive tre...